MA47398A - Immunothérapie à base de vecteurs d'administration personnalisés et utilisations associées - Google Patents
Immunothérapie à base de vecteurs d'administration personnalisés et utilisations associéesInfo
- Publication number
- MA47398A MA47398A MA047398A MA47398A MA47398A MA 47398 A MA47398 A MA 47398A MA 047398 A MA047398 A MA 047398A MA 47398 A MA47398 A MA 47398A MA 47398 A MA47398 A MA 47398A
- Authority
- MA
- Morocco
- Prior art keywords
- immunotherapy based
- associated uses
- personalized administration
- administration vectors
- vectors
- Prior art date
Links
- 238000009169 immunotherapy Methods 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0331—Animal model for proliferative diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662287871P | 2016-01-27 | 2016-01-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA47398A true MA47398A (fr) | 2019-12-11 |
Family
ID=59398812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA047398A MA47398A (fr) | 2016-01-27 | 2017-01-27 | Immunothérapie à base de vecteurs d'administration personnalisés et utilisations associées |
Country Status (11)
Country | Link |
---|---|
US (1) | US20190032064A1 (fr) |
EP (1) | EP3408395A4 (fr) |
JP (1) | JP2019503186A (fr) |
KR (1) | KR20180100443A (fr) |
CN (1) | CN108884468A (fr) |
AU (1) | AU2017211387A1 (fr) |
CA (1) | CA3012829A1 (fr) |
MA (1) | MA47398A (fr) |
MX (1) | MX2018009225A (fr) |
SG (1) | SG11201806392XA (fr) |
WO (1) | WO2017132547A1 (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9012141B2 (en) | 2000-03-27 | 2015-04-21 | Advaxis, Inc. | Compositions and methods comprising KLK3 of FOLH1 antigen |
CN103687611A (zh) | 2011-03-11 | 2014-03-26 | 阿德瓦希斯公司 | 基于李斯特菌属的佐剂 |
KR20140134695A (ko) | 2012-03-12 | 2014-11-24 | 어드박시스, 인크. | 리스테리아 백신 치료 후 억제 세포 기능 저해 |
BR112016019057A2 (pt) | 2014-02-18 | 2017-10-10 | Advaxis Inc | método de induzir uma resposta imune contra uma doença em um indivíduo |
KR102491332B1 (ko) | 2014-04-24 | 2023-01-27 | 어드박시스, 인크. | 재조합 리스테리아 백신 균주 및 그 생산 방법 |
MA41644A (fr) | 2015-03-03 | 2018-01-09 | Advaxis Inc | Compositions à base de listeria comprenant un système d'expression de minigènes codant pour des peptides, et leurs procédés d'utilisation |
EP3548623A4 (fr) | 2016-11-30 | 2020-11-25 | Advaxis, Inc. | Compositions immunogènes ciblant des mutations récurrentes du cancer et leurs procédés d'utilisation |
CN111356760A (zh) | 2017-09-19 | 2020-06-30 | 阿德瓦希斯公司 | 细菌或李斯特菌菌株的冻干组合物和方法 |
KR20200130339A (ko) * | 2018-03-06 | 2020-11-18 | 프레시전 인코포레이티드 | 사람 파필로마바이러스 백신 및 이의 용도 |
CN110408634B (zh) * | 2018-04-27 | 2021-08-03 | 苏州若泰医药科技有限公司 | 一种非整合李斯特菌疫苗及抗肿瘤免疫应答方法 |
CN111334521B (zh) * | 2018-12-18 | 2022-02-18 | 上海若泰医药科技有限公司 | 一种提高非整合减毒李斯特菌外源抗原蛋白表达的方法 |
EP3937973A1 (fr) * | 2019-03-11 | 2022-01-19 | Evaxion Biotech A/S | Vaccination par acides nucléiques au moyen de constructions de codage de néoépitopes |
EP4076507A1 (fr) * | 2019-12-18 | 2022-10-26 | Evaxion Biotech A/S | Vaccination par acides nucléiques au moyen de constructions codant pour des néo-épitopes |
KR20230049061A (ko) * | 2020-05-14 | 2023-04-12 | 넛크래커 테라퓨틱스 인코포레이티드 | 항원 페이로드를 포함하는 폴리뉴클레오티드 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2283112B1 (fr) * | 2008-05-19 | 2016-10-12 | Aduro Biotech | Compositions comportant un mutant prfa de listeria, et leurs procédés d'utilisation |
US9017660B2 (en) * | 2009-11-11 | 2015-04-28 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors |
BR112016019057A2 (pt) * | 2014-02-18 | 2017-10-10 | Advaxis Inc | método de induzir uma resposta imune contra uma doença em um indivíduo |
-
2017
- 2017-01-27 AU AU2017211387A patent/AU2017211387A1/en not_active Abandoned
- 2017-01-27 EP EP17744997.2A patent/EP3408395A4/fr not_active Withdrawn
- 2017-01-27 MA MA047398A patent/MA47398A/fr unknown
- 2017-01-27 SG SG11201806392XA patent/SG11201806392XA/en unknown
- 2017-01-27 US US16/073,194 patent/US20190032064A1/en not_active Abandoned
- 2017-01-27 MX MX2018009225A patent/MX2018009225A/es unknown
- 2017-01-27 CN CN201780020675.4A patent/CN108884468A/zh active Pending
- 2017-01-27 KR KR1020187024523A patent/KR20180100443A/ko unknown
- 2017-01-27 WO PCT/US2017/015403 patent/WO2017132547A1/fr active Application Filing
- 2017-01-27 CA CA3012829A patent/CA3012829A1/fr not_active Abandoned
- 2017-01-27 JP JP2018539059A patent/JP2019503186A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2019503186A (ja) | 2019-02-07 |
AU2017211387A1 (en) | 2018-08-16 |
WO2017132547A1 (fr) | 2017-08-03 |
CA3012829A1 (fr) | 2017-08-03 |
SG11201806392XA (en) | 2018-08-30 |
KR20180100443A (ko) | 2018-09-10 |
US20190032064A1 (en) | 2019-01-31 |
CN108884468A (zh) | 2018-11-23 |
EP3408395A4 (fr) | 2019-12-11 |
EP3408395A1 (fr) | 2018-12-05 |
MX2018009225A (es) | 2019-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA47398A (fr) | Immunothérapie à base de vecteurs d'administration personnalisés et utilisations associées | |
MA43362A (fr) | Immunothérapie à base de vecteurs d'administration personnalisés, et leurs utilisations | |
MA45280A (fr) | Conjugués anticorps-médicament à base d'éribuline et leurs procédés d'utilisation | |
MA45306A (fr) | Mise à jour d'une carte électroanatomique | |
DK3532499T3 (da) | ANTI-IL-33-antistoffer og anvendelser deraf | |
DK3402821T3 (da) | Psma-bindende antistof og anvendelser deraf | |
DK3548135T3 (da) | Kerne-skal-mikronålsindretninger og anvendelser deraf | |
MA49122A (fr) | Peptides et combinaisons de peptides destinés à être utilisés en immunothérapie anticancéreuse | |
MA48596A (fr) | Caractéristique d'inertie | |
DK3448419T3 (da) | Interferon-beta-antistoffer og anvendelser deraf | |
IT201700050753A1 (it) | Dispositivo indossabile di ausilio contro le cadute | |
MA43873A (fr) | Dspositif d'injection | |
MA49259A (fr) | Anticorps thérapeutiques à base d'hexamères d'igg mutées | |
EP3568148C0 (fr) | Peptides de chaperonine 60.1 de mycobacterium tuberculosis et leurs utilisations | |
MA41270A (fr) | Dispositif de massage de type à poches d'air | |
ITUA20163609A1 (it) | "micro-cogeneratore". | |
MA49454A (fr) | Formulations ophtalmiques à base de tropicamide | |
IT201700090331A1 (it) | "lopemide" | |
IT201700071679A1 (it) | Remembebe' | |
IT201700112534A1 (it) | Capo d'abbigliamento | |
DK3417057T3 (da) | Arabinanase og anvendelser deraf | |
MA46281A (fr) | Anticorps anti-muc16 (mucine 16) | |
TH178766B (th) | "กระเป๋า" | |
IT201700008760U1 (it) | Posteggio per biciclette e simili | |
TH183331B (th) | "องค์ประกอบทำให้ผิวสว่างขึ้นที่ประกอบรวมด้วย 4-เฮกซิลรีซอร์ซินอล และอิโลมาสแตท" |